AI Summary

A recent study conducted by Stanford Medicine investigators has found a correlation between estrogen-based menopausal hormone therapy and a lower risk of Alzheimer's disease. The study focused on women who were prescribed estrogen-only therapy, which is typically used by women who have had a hysterectomy. This type of therapy is distinct from combined hormone therapy, which includes both estrogen and progesterone. The findings suggest that women on estrogen-only therapy may have a reduced risk of developing Alzheimer's disease, although the study does not provide information on the underlying mechanisms or the long-term implications of this correlation.

AI summaries can be wrong sometimes—always verify important details using the source article.